Synapse - Gastrointestinal Oncology Service

Results (4744)

Preliminary clinical and biologic results of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab, in advanced solid tumors (KEYNOTE A36)

Meeting Abstract

Park, H.; Bendell, J. C.; Messersmith, W. A.; Rasco, D. W.; De Bono, J. S.; Strickler, J. H.; Zhou, L.; Carter, L. L.; Bruey, J. M.; Li, J.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

A randomized phase III study of immune checkpoint inhibition with chemotherapy in treatment-naive metastatic anal cancer patients: A trial of the ECOG-ACRIN cancer research group (EA2176)

Meeting Abstract

Roth, M. T.; Catalano, P. J.; Ciombor, K. K.; Benson, A. B.; Yao, X.; Yaeger, R.; Salem, M. E.; Morris, V. K.; Henry, D. H.; Whisenant, J. G.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Improving outcomes and shared decisions in pancreatic cancer using animated pancreas patient (APP) visual formats of learning: A National Pancreas Foundation (NPF) patient education initiative

Meeting Abstract

Munigala, S.; O'Reilly, E. M.; Alsante, M.; Holt, J.; Ko, A. H.; Gelrud, A.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

MATTERHORN: Efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer - A randomized, double-blind, placebo-controlled, phase 3 study

Meeting Abstract

Janjigian, Y. Y.; Van Cutsem, E.; Muro, K.; Wainberg, Z. A.; Al-Batran, S. E.; Hyung, W. J.; Molena, D.; Evans, B.; Ruscica, D.; Robbins, S. H.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Genetic predictor of severe sorafenib-induced diarrhea and hand-foot syndrome (HFS)

Meeting Abstract

Quintanilha, J. C. F.; Geyer, S. M.; Wang, J.; Etheridge, A.; Denning, S.; Racioppi, A.; Hammond, K.; Crona, D.; Pena, C. E.; Jacobson, S. B.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

T-cell receptor pharmacodynamics associated with survival and response to tremelimumab (T) in combination with durvalumab (D) in patients (pts) with unresectable hepatocellular carcinoma (uHCC)

Meeting Abstract

McCoon, P.; Lee, Y. S.; Kelley, R. K.; Guthrie, V. B.; Wu, S.; Bien, S. A.; Negro, A.; He, P.; Kurland, J.; Barrett, J. C.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part B (pembrolizumab plus chemotherapy)

Meeting Abstract

Chan, J. A.; Raj, N. P.; Aggarwal, R. R.; Calabrese, S.; DeMore, A.; Dhawan, M. S.; Fattah, D.; Fong, L.; Grabowsky, J.; Hope, T. A.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Computational extraction and analysis of de-identified medical records to characterize hyperammonemia in patients with fibrolamellar carcinoma (FLC)

Meeting Abstract

Zack, T.; Maisel, S.; O'Neill, A. F.; La Quaglia, M. P.; Herman, M.; Knox, J. J.; Yaqubie, A.; Venook, A. P.; Mayer, R. J.; Gordan, J. D.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

First-in-human phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study of oral GNS561, a palmitoyl-protein thioesterase 1 (PPT1) inhibitor, in patients with primary and secondary liver malignancies

Meeting Abstract

Harding, J. J.; Awada, A.; Decaens, T.; Roth, G.; Merle, P.; Kotecki, N.; Dreyer, C.; Ansaldi, C.; Rachid, M.; Mezouar, S.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Disparity between the use of postoperative psychosocial and physical services among older adults with head and neck cancer

Meeting Abstract

Raab, G. T.; Restifo, D.; Tin, A. L.; Zakeri, K.; Shahrokni, A.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save